Almirall delivers robust H1 performance and increases full-year guidance

BARCELONA, Spain, July 26, 2021 /PRNewswire/ -- Almirall, S.A. (BME: ALM), the global biopharmaceutical company based in Barcelona, has announced its H1 2021 financial results. Summary of results H1 Core Net Sales* reached €415.5 MM, an 8% year-on-year increase with positive contribution...

from PR Newswire: https://ift.tt/3kXgc6q